STE
STERIS plc
NYSE · Healthcare · Medical - Devices · IE
$224.82
−0.89%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
19.6x
EV/EBITDA
13.0x
Market Cap
$21.92B
MomentumView details →
1D Return
−0.89%
YTD Return
−11.49%
RSI (14)
40.0
ValuationView details →
P/E (Fwd)
19.6x
EV/EBITDA
13.0x
Market Cap
$21.92B
RSI (14)
40.0
MomentumView details →
1D Return
−0.89%
YTD Return
−11.49%
SummaryUpdated Jun 1, 2026
STERIS plc (NYSE:STE) is an Irish-domiciled multinational corporation that provides infection prevention and procedural products and services to healthcare facilities, pharmaceutical manufacturers, and medical device companies worldwide. Founded in 1985 and publicly traded since 1992, the company has grown through strategic acquisitions and organic expansion to become a leading provider of sterilization, disinfection, and surgical equipment solutions. STERIS operates through four main business segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental, serving customers across hospitals, pharmaceutical companies, medical device manufacturers, and dental practices globally.
Similar companies
Latest newsMore news →
STERIS announced a $600 million investment to build a new chemistry manufacturing, research and distribution complex in North Carolina.26d agoSTERIS plc announced its financial results for the fiscal 2027 first quarter ended June 30, 2026, reporting total revenue of $1.5 billion, a 7% increase from $1.4 billion in the prior-year quarter, with constant currency organic revenue growth of 6%.30d agoSTERIS announced a $600 million investment to build a Formulated Chemistries manufacturing and distribution Center of Excellence in North Carolina, supporting sterilization and disinfection for global healthcare and pharmaceutical industries.30d ago